Getting Here | Contact Us | A to Z of Services                          

                                            




You are here  : Home FOI Responses FOI Requests in 2010 FOI Requests in 2010 FOI Request 2170 - Haematology Treatment
FOI Request 2170 - Haematology Treatment
Written by FOI Lead   

Case Number 2170
Request Date 15/09/2010

Details of the Request


  1. Data relating to the treatment of patients with Idiopathic (immune) thrombocytopenic purpura (ITP)
  2. Haematology Treatment
  3. The treatment of patients with specific conditions

Completion Date 04/10/2010


Details of the Response

Thank you for your request to Ashford and St. Peter’s Hospitals NHS Trust. Please see the response below:
  1. Data relating to the treatment of patients with Idiopathic (immune) thrombocytopenic purpura (ITP)

    Treatment for patients with Idiopathic (immune) thrombocytopenic purpura (ITP) Number of ITP patients currently* receiving the treatment Number of ITP patients who have received the treatment in the last 12 months
    A1 - Eltrombopag    
    A2 - Romiplostim    
    A3 - IVIg (immunoglobulin) 4 9
    A4 - Steroids 2 5
    A5 - Rituxumab 1 1
    A6 - Other treatments    
    A7 - Specify the other treatments    


    * Currently - the number of patients under the care of a Trust physician who are, at the present time, receiving the drug treatment, either as an inpatient or outpatient. 

     
  2. Haematology Treatment

    B1 - Within the haematology consultant group, is/are there select individual haematologists who either specialise in ITP, or to whom the other haematologists (either within your own trust or from other trusts) refer ITP patients? All three haematologists manage patients with ITP but one leads in thrombosis and bleeding disorders and manages all patients with ITP during pregnancy
    B2 - If yes would you please give their names Dr Tanya Bernard, Dr Andrew Laurie & Dr Anne Miller
    B3 - In the last 12 months, how many business cases were submitted from haematologists requesting funding for ITP Patients None
    B4 - The number of patients involved in the business cases in B3 n/a
    B5 - In the last 12 months, the number of individual funding requests submitted from haematologists requesting funding for ITP Patients n/a
    B6 - The number of those indivdual funding requests that were approved n/a

     
  3. The treatment of patients with specific conditions

    Condition Treatment Number of patients currently* being treated
    C1 - Rheumatoid Arthritis Abatacept 0
    C2 - Alzheimer's Donepezil 199 *


    * Currently - the number of patients under the care of a Trust physician who are, at the present time, receiving the drug treatment, either as an inpatient or outpatient.
     
Number of patients issued Donepezil in past 12 months:

The number of patients issued Donepezil in the past 12 months does not include those pateints prescribed Donepezil on FP (HP) 10 prescriptions. The 199 patients encompasses inpatient and discharge issues,but not FP (HP) 10 as this data is difficult to obtain.


Last Updated ( Tuesday, 31 May 2011 14:58 )